Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T.   Carlsson L.   Einbeigi Z.   Lidbrink E.   Linderholm B.   Lindh B.   Loman N.   Malmberg M.   Rotstein S.   Söderberg M.   Sundquist M.   Walz T.   Hellström M.   Svensson H.   Åström G.   Brandberg Y.   Carstensen J.   Fernö M.   Bergh J.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer

By Tortoriello A.  

Breast Cancer Research and Treatment, Vol. 47, Iss. 1, 1998-01 ,pp. : 91-97

Springer Publishing Company

Access to resources Recommend Favorite

Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation

By Haines Terry  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 163-175

Springer Publishing Company

Access to resources Recommend Favorite

Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial

By van Poznak C.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 3, 2001-04 ,pp. : 239-248

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

By Cristofanilli M.   Holmes F.A.   Esparza L.   Valero V.   Buzdar A.U.   Neidhart J.A.   Hortobagyi G.N.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 3, 1999-04 ,pp. : 225-233

Springer Publishing Company

Access to resources Recommend Favorite